XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Loss per Common Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Anti-dilutive securities excluded from the computation of earnings per share
The following potentially dilutive securities were excluded from the computation of earnings per share as of September 30, 2022 and 2021 because their effects would be anti-dilutive:
 
    
September 30,
 
    
2022
    
2021
 
Common stock warrants - equity
     4,461,249        3,894,509  
Assumed conversion of Series E and Series
E-1
Preferred Stock
     1,135,721        1,170,721  
Assumed conversion of convertible notes
     488,031        488,031  
Stock options
     2,249,955        1,698,249  
    
 
 
    
 
 
 
Total
     8,334,956        7,251,510  
    
 
 
    
 
 
 
Summary of reconciliation of weighted average shares outstanding calculation The following table provides a reconciliation of the weighted average shares outstanding calculation for the three and nine months ended September 30, 2022 and 2021:
 
    
Three months ended
September 30,
    
Nine months ended
September 30,
 
    
2022
    
2021
    
2022
    
2021
 
Weighted average shares issued
     8,470,006        7,354,428        8,096,551        6,665,826  
Weighted average
pre-funded
warrants
     745,780        233,215        439,455        257,715  
    
 
 
    
 
 
    
 
 
    
 
 
 
Weighted average shares outstanding
     9,215,786        7,587,643        8,536,006        6,923,541